Clinical research of S-1 plus intravenous and intraperitoneal paclitaxel for gastric cancer with peritoneal metastasis or positive peritoneal cytology
Not Applicable
- Conditions
- gastric cancer with peritoneal metastasis or positive peritoneal cytology
- Registration Number
- JPRN-UMIN000023620
- Lead Sponsor
- The University of Tokyo Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1) Distal metastasis other than to the peritoneum, ovary and abdominal lymph nodes 2) Contraindication to S-1 or paclitaxel 3) Apparent infection or inflammation 4) Severe heart disease 5) Severe complication 6) Gastrointestinal tract bleeding requiring blood transfusion 7) Pregnancy, breast feeding or intention to become pregnant 8) Judged inappropriate for this trial for other reasons
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety
- Secondary Outcome Measures
Name Time Method overall survival response rate negative conversion rate on peritoneal cytology